-
2024-515445-42-00
5
2025-03-24
Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast
-
2024-513009-30-00
4
2024-11-21
Moderate to Severe Crohn’s Disease
-
2024-512113-41-00
5
2024-11-20
Severe Asthma
-
2023-506632-32-00
5
2024-10-28
Metastatic colorectal cancer
-
2022-502559-69-01
4
2024-07-04
advanced (FIGO stage IIIA, IIIB, IIIC, or IV of the 2014 FIGO classifi
-
2023-503219-14-01
10
2024-05-22
systemic sclerosis associated interstitial lung disease
-
2024-511397-70-00
4
2024-05-06
metastatic renal cell carcinoma (mRCC)
-
2022-501453-36-00
5
2024-02-23
Breast cancer
-
2022-502021-18-00
6
2023-10-12
Rheumatoid Arthritis
-
2022-500587-35-01
5
2023-07-06
Stroke
-
2024-515681-14-00
4
2022-05-02
Stage II (pT4)/III colorectal cancer with positive circulating tumor D
-
2024-518534-81-00
4
2021-07-01
metastatic colorectal cancer
-
2024-519007-10-00
10
2020-10-22
Locally advanced stage II/III rectal cancer
-
2024-518998-33-00
5
2025-07-23
Ulcerative Colitis
-
2024-512180-31-00
4
2025-03-14
Oligometastatic renal cell carcinoma
-
2023-508636-61-00
5
2024-10-24
Crohn’s Disease
-
2023-508219-21-00
5
2024-09-12
BTC - Biliary Tract Cancer
-
2023-509088-26-00
4
2024-07-22
Metastatic colorectal cancer
-
2023-508359-38-00
5
2024-06-05
Early-stage Non-squamous Non-small Cell Lung Cancer
-
2023-503265-27-00
5
2023-11-23
Participants with Untreated T4N0 or Stage III dMMR/MSI-H Resectable Co
-
2024-511169-12-00
5
2023-03-28
Non-Small Cell Lung Cancer
-
2023-504741-32-00
4
2022-11-30
Moderately to Severely Active Crohn's Disease
-
2023-504743-13-00
4
2022-11-30
Moderately to Severely Active Ulcerative Colitis
-
2023-506241-30-00
5
2021-11-30
Advanced Colorectal Cancer with KRAS G12C Mutation